{
    "clinical_study": {
        "@rank": "124499", 
        "arm_group": [
            {
                "arm_group_label": "Curcumin", 
                "arm_group_type": "Active Comparator", 
                "description": "Curcumin 500 mg orally twice a day"
            }, 
            {
                "arm_group_label": "sugar pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo orally twice a day"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective study to determine if the adjuvant use of Curcumin improves\n      recurrence-free survival."
        }, 
        "brief_title": "Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy", 
        "completion_date": {
            "#text": "June 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective study to determine if the adjuvant use of Curcumin improves\n      recurrence-free survival in patients after radical prostatectomy compared to placebo"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  radical prostatectomy for adenocarcinoma of prostate\n\n          -  pathologically confirmed T1-T3 disease\n\n          -  no sign of lymph node or metastatic disease\n\n          -  Eastern Cooperative Oncology Group(ECOG) status 0-2\n\n          -  adequate renal and liver function\n\n          -  no plan to receive adjuvant hormone or radiation therapy\n\n          -  life expectancy of 3 years\n\n        Exclusion Criteria:\n\n          -  must not have exceeded 3 months from time of surgery to enrollment into study\n\n          -  T3b or T4 or node positive disease\n\n          -  hormone therapy before surgery\n\n          -  history of gallbladder problems or gallstones, or biliary obstruction\n\n          -  radiation therapy as primary treatment after surgery\n\n          -  antiplatelet or anticoagulant agents\n\n          -  history of gastric or duodenal ulcers or hyperacidity syndromes"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064673", 
            "org_study_id": "042013-080"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Curcumin", 
                    "sugar pill"
                ], 
                "description": "Curcumin or placebo 500mg by mouth twice a day for 6 months", 
                "intervention_name": "Curcumin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Bio-Curcumin(BCM-95CG)", 
                    "Tumeric"
                ]
            }, 
            {
                "arm_group_label": [
                    "Curcumin", 
                    "sugar pill"
                ], 
                "description": "placebo orally twice a day", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug", 
                "other_name": "sugar pill"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Curcumin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "prostate cancer", 
            "radical prostatectomy"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "contact": {
                "email": "Allison.Beaver@utsouthwestern.edu", 
                "last_name": "Allison Beaver, RN, BSN", 
                "phone": "214-645-8787"
            }, 
            "facility": {
                "address": {
                    "city": "Dallas", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "75390"
                }, 
                "name": "UT Southwestern Medical Center"
            }, 
            "investigator": {
                "last_name": "Yair Lotan, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Trial of Adjuvant Curcumin After Prostatectomy", 
        "overall_contact": {
            "email": "Allison.Beaver@utsouthwestern.edu", 
            "last_name": "Allison Beaver, RN, BSN", 
            "phone": "214-645-8787"
        }, 
        "overall_official": {
            "affiliation": "UT Southwestern Medical Center", 
            "last_name": "Yair Lotan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Recurrence free survival defined as a total serum prostate specific antigen of <0.2ng/ml.", 
            "measure": "Serum prostate specific antigen", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064673"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Texas Southwestern Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Texas Southwestern Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}